Small colony variants in Staphylococcal infections: Diagnostic and therapeutic implications

Clinical Infectious Diseases

Volumn 27, Issue 3, 1998, Pages 419-423

  Proctor, Richard A ^a   Peters, Georg ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; COTRIMOXAZOLE; GENTAMICIN; HEMIN; MENADIONE; RIFAMPICIN; THIAMINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM COLONY; CYSTIC FIBROSIS; ELECTRON TRANSPORT; HUMAN; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0031715560     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514706     Document Type: Article

References (12)

1. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persistent and relapsing infections associated with small colony variants of Staphylococcus aureus. Clin Infect Dis 1995;20:95-102.
2. Balwit JM, van Langevelde P, Vann JM, Proctor RA. Gentamicin-resistant, menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis 1994;170:1033-7.
3. Vesga O, Vann JM, Brar D, Proctor RA. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 1996;173:739-42.
4. Proctor A. Microbial pathogenic factors: small colony variants. In: Bisno AL, Waldvogel FA, eds. Infections associated with indwelling medical devices. 2nd ed. Washington, DC: American Society for Microbiology, 1994:77-90.
5. Proctor RA, Balwit JM, Vesga O. Variant subpopulations of Staphylococcus aureus can cause persistent and recurrent infections. Infectious Agents and Disease 1994;3:302-12.
6. Vann JM, Proctor RA. Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus α-hemolysin. Microb Pathog 1998;4:443-53.
7. Kahl B, Herrmann M, Schulze-Everding A, et al. Persistent infection with small colony variants of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998;177:1023-9.
8. Koo SP, Bayer AS, Sahl H-G, Proctor RA, Yeaman MR. Staphylocidal action of thrombin-induced platelet microbiocidal protein (tPMP) is not solely dependent on transmembrane potential (ΔΨ). Infect Immun 1996; 64:1070-4.
9. von Eiff C, Bettin D, Proctor RA, et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 1997;25:1250-1.
10. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Götz F. A site directed Staphylococcus aureus hemB mutant is a small colony variant which persists intracellularly. J Bacteriol 1997;179:4706-12.
11. Kahl B, von Eiff C, Herrmann M, Peters G, Proctor RA. Staphylococcal small colony variants present a challenge to clinicians and clinical microbiologists. Antibiotics and Infectious Diseases Newsletter 1998;15: 59-63.
12. Chuard C, Vaudaux PE, Proctor RA, Lew DP. Decreased susceptibility to antibiotic killing of small colony variants of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother 1997;39:603-8.